US Senate Finance Committee chairman Chuck Grassley and ranking member Ron Wyden have introduced a bipartisan bill aimed at lowering drug prices in the country.
Pharma bosses faced a grilling from the US Senate’s Finance Committee over the high price of branded prescription drugs in the US compared with other developed countries.